Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

34 trials with published results (9%)

Research Maturity

214 completed trials (59% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.4%

16 terminated out of 362 trials

Success Rate

93.0%

+6.5% vs benchmark

Late-Stage Pipeline

17%

60 trials in Phase 3/4

Results Transparency

16%

34 of 214 completed with results

Key Signals

34 with results93% success16 terminated

Data Visualizations

Phase Distribution

291Total
Not Applicable (208)
Early P 1 (4)
P 1 (5)
P 2 (14)
P 3 (7)
P 4 (53)

Trial Status

Completed214
Unknown52
Recruiting34
Not Yet Recruiting27
Terminated16
Withdrawn11

Trial Success Rate

93.0%

Benchmark: 86.5%

Based on 214 completed trials

Clinical Trials (362)

Showing 20 of 20 trials
NCT07717983Not ApplicableNot Yet Recruiting

Abdominopelvic Fascial Release for Post-Cesarean Menstrual Pain and Scar Mobility

NCT07729254Not Yet RecruitingPrimary

Association Between Cesarean Scar Mobility and Menstrual Pain in Post-Cesarean Women

NCT07730060Not ApplicableNot Yet RecruitingPrimary

Intraperitoneal Saline Irrigation in Cesarean Section

NCT07689825Not Yet RecruitingPrimary

Development of a Risk Prediction Model for Post-Spinal Anesthesia Hypotension During Cesarean Delivery Using Heart Rate, Blood Pressure, Perfusion Index, ECG Waveforms, and SpO₂ Waveforms

NCT07720440Not ApplicableCompletedPrimary

Nociception Level Index Monitoring During Cesarean Section

NCT07720986Not ApplicableCompletedPrimary

Enhanced Recovery Protocol After Cesarean Section

NCT07521592Not ApplicableCompleted

Effect of Video-Based Versus Verbal Preoperative Information on Anxiety and Cortisol Levels in Elective Cesarean Section

NCT06282952Not ApplicableRecruiting

Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation

NCT07715409Not ApplicableNot Yet RecruitingPrimary

Effect of Betadine Vaginal Cleansing Before Cesarean Section to Reduce Postoperative Infectious Morbidity

NCT07712510Phase 4Completed

Tranexamic Acid Versus Misoprostol to Reduce Blood Loss During and After Cesarean Section

NCT07696325Not ApplicableCompleted

Education of Pregnant Women With a Prenatal Indication for Cesarean Section Through Periodic Short Message Service (SMS) and Interactive Voice Response System (IVR) in Uganda

NCT07686913Not ApplicableRecruitingPrimary

Steri-Strip Application Versus Standard Wound Closure for Cesarean Section Incisions

NCT07549776Not ApplicableCompleted

Ultrasound-guided Versus Landmark-based Spinal Anesthesia in Obese Parturients Undergoing Cesarean Section

NCT07511491Not ApplicableRecruiting

Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section

NCT06418308Phase 4CompletedPrimary

Intrathecal Dexmedetomidine vs Epinephrine

NCT01211431Phase 4WithdrawnPrimary

Post-cesarean Pain Control Via Continuous Infusion of Ropivacain et Diclogenac Into the Wound Versus Intathecal Morphine

NCT04955847Completed

Efficacy and Safety of Oral Misoprostol 25 μg vs. Vaginal Dinoprostone in Induction of Labor at Term

NCT07334418Not ApplicableRecruitingPrimary

Early General Anesthesia to Limit Experiences of Trauma During Cesarean Section-Pilot Study

NCT07636421Phase 4Not Yet Recruiting

Carbetocin Monotherapy Versus Carbetocin Plus Oxytocin Infusion in Elective Cesarean Delivery: A Non-Inferiority Trial

NCT07223775Not ApplicableCompletedPrimary

Kangaroo Care in the Operating Room

Scroll to load more

Research Network

Activity Timeline